Introduction: Neuroendocrine Tumors (NETs) are slowly growing tumors with an indolent course. NETs often present with liver metastasis, and most of these tumors are inoperable at the time of presentation. Transarterial (chemo)embolization [TA(C)E] is widely available to manage liver metastasis of NET.
Aim(s): To evaluate the efficacy and adverse events in patients with NET treated with TA(C)E.
Materials and methods: Forty-three patients with metastatic neuroendocrine tumors who underwent TA(C)E between December 1999 and June 2013 in National Cancer Center Hospital and National Cancer Center Hospital East were included in this retrospective study. We assessed the tumor response, disease control rate, progression-free survival, and adverse events of TA(C)E.
Conference: 11th Annual ENETS Conference 2014 (2014)
Category: Medical treatment - Others
Presenting Author: Hiroyuki Okuyama
, Takahashi H
, Ohno I
, Shimizu S
, Mitsunaga S
, Kondo S
, Morizane C
, Ueno H
, Satake M
, Arai Y
, Okusaka T
, Ikeda M
To read results and conclusion, please login ...
Further abstracts you may be interested in